Silexion Therapeutics (SLXNW) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-4.32
-3.14
-1.95
-0.77

Details

Expected EPS
-3.4
Actual EPS
-2.88
Surprise EPS
0.52
Surprise Percent
+15.29%

Description

Silexion Therapeutics (SLXNW) has reported earnings of -2.88 per share for Q4 2025.

0 Comments

Share your thoughts